1.Dewan PK, et al. Inhalational anthrax outbreak among postal workers, Washington, DC, 2001. Emerging Infectious Diseases 2002; 8: 1066–1072.
2.Bell JH, Fee E, Brown TM. Anthrax and the wool trade. 1902. American Journal of Public Health 2002; 92: 754–757.
3.Brachman PS, Fekety FR. Industrial anthrax. Annals of the New York Academy of Sciences 1958; 70: 574–584.
4.Bales ME, et al. Epidemiologic response to anthrax outbreaks: field investigations, 1950–2001. Emerging Infectious Diseases 2002; 8: 1163–1174.
5.Brachman PS, et al. An epidemic of inhalation anthrax: the first in the twentieth century. II. Epidemiology. American Journal of Hygiene 1960; 72: 6–23.
6.Pfisterer RM. An anthrax epidemic in Switzerland. Clinical, diagnostic and epidemiological aspects of a mostly forgotten disease [in German]. Schweizerische Medizinische Wochenschrift 1991; 121: 813–825.
7.Metcalfe N. The history of woolsorters' disease: a Yorkshire beginning with an international future? Occupational Medicine 2004; 54: 489–493.
8.Anon.Probable human anthrax death in Scotland Eurosurveillance 2006; 11: E060817 060812.
9.Anaraki S, et al. Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008. Eurosurveillance 2008; 13.
10.Centers for Disease Control and Prevention (CDC).Cutaneous anthrax associated with drum making using goat hides from West Africa – Connecticut, 2007. Morbidity and Mortality Weekly Report 2008; 57: 628–631.
11.Norman PS, et al. Serologic testing for anthrax antibodies in workers in a goat hair processing mill. American Journal of Hygiene 1960; 72: 32–37.
12.Doolan DL, et al. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. Journal of Infectious Diseases 2007; 195: 174–184.
13.Wattiau P, et al. Occurrence and genetic diversity of Bacillus anthracis strains isolated in an active wool-cleaning factory. Applied and Environmental Microbiology 2008; 74: 4005–4011.
14.Wattiau P, et al. Immunologic response of unvaccinated workers exposed to anthrax, Belgium. Emerging Infectious Diseases 2009; 15: 1637–1640.
15.Biagini RE, et al. Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay. Occupational and Environmental Medicine 2004; 61: 703–708.
16.Hadler JL. Learning from the 2001 anthrax attacks: immunological characteristics. The Journal of Infectious Diseases 2007; 195: 163–164.
17.Dahlgren CM, et al. Bacillus anthracis aerosols in goat hair processing mills. American Journal of Hygiene 1960; 72: 24–31.
18.Fennelly KP, et al. Airborne infection with Bacillus anthracis – from mills to mail. Emerging Infectious Diseases 2004; 10: 996–1002.
19.Communicable Disease Center.Inhalation anthrax – Delaware County, Pennsylvania. Morbidity and Mortality Weekly Report 1961; 10: 2.
20.Sanderson WT, et al. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center. Journal of Applied Microbiology 2004; 96: 1048–1056.
21.Grunow R, et al. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine 2007; 25: 3679–3683.
22.Quinn CP, et al. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. Journal of Infectious Diseases 2004; 190: 1228–1236.
23.Abboud N, Casadevall A. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background. Clinical and Vaccine Immunology 2008; 15: 1115–1123.
24.Swartz MN. Recognition and management of anthrax – an update. New England Journal of Medicine 2001; 345: 1621–1626.
25.Van den Enden E, Van Gompel A, Van Esbroeck M. Cutaneous anthrax, Belgian traveler. Emerging Infectious Diseases 2006; 12: 523–525.